Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs

Drug repositioning is the only feasible option to immediately address the COVID-19 global challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which were preselected by an assay of SARS-CoV. We identified 24 potential antiviral...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Jeon, Sangeun, Ko, Meehyun, Lee, Jihye, Choi, Inhee, Byun, Soo Young, Park, Soonju, Shum, David, Kim, Seungtaek
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2020
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318052/
https://ncbi.nlm.nih.gov/pubmed/32366720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00819-20
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados